Navigation Links
Cytopia Commences Phase II Cancer Drug Study
Date:12/17/2007

$3 billion by 2013.

Cytopia is also currently conducting a Phase I study investigating the safety and tolerability of CYT997 following oral administration. The company also intends to file regulatory applications in support of other Phase II studies over the coming months.

The following table provides a summary of the key aspects of the Phase II multiple myeloma trial.

Name of trial A prospective, single-arm, two-stage, open-label

Phase II trial of CYT997 in relapsed and

refractory multiple myeloma (CCL07001)

Primary endpoints Determination of the overall response rate to CYT997

Secondary endpoints Time to progression; number of cycles of CYT997 to

achieve maximum response; overall survival and

safety and tolerability

Blinding status Not blinded

Product development Drug substance and drug product are manufactured to

status GMP standards

Treatment method

Route 24 hour intravenous infusion dose

Frequency Days 1 and 8 of a 21 day cycle

Dose-levels 202 mg/m2 CYT997 dihydrochloride

Number of trial 24 patients maximum

subjects

Subject selection Eligible patients must have a diagnosis of

criteria multiple myeloma (per World Health Organisation

criteria) and have received at least one but no

more than three previous lines of therapy

Trial location Melbourne, Australia

Expected completion Interim analysis (14 patients) Q3, 2008

Trial standard ICH-GCP

About Cytopia

Cytopia Ltd is an Australian biotechnology company focused on the discovery and development of new drugs to treat cancer. Cytopia conducts its research and development via subsidiaries based in
'/>"/>

SOURCE Cytopia Limited
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Exelixis Commences Public Offering of Common Stock
3. Milestone Scientific Commences Declaratory Judgment Action With Respect to Its Single Tooth Anesthesia (STA(TM)) System and Compudent(TM) System
4. American Physicians Capital, Inc. Completes $15 Million Authorization and Commences $20 Million Authorization Under Stock Repurchase Program
5. Amarin Commences First Clinical Trial in Cardiovascular ProgramAmarin Commences First Clinical Trial in Cardiovascular Program
6. Ovation further advances development pipeline with new phase III epilepsy study
7. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
8. Mannatech Launches Phase One of New Sales and Training Tools
9. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
10. Manic phase of bipolar disorder benefits from breast cancer medication
11. ARIZONA METH PROJECT Unveils Arizonas Anti-Meth Youth Pledge and Kicks Off Phase Two of Public Awareness Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... ... July 03, 2015 , ... ... sessions and speaker lineup for its 2015 Annual Conference , the ... 6-8, 2015 at the Renaissance Orlando at SeaWorld in Orlando, Florida. Speakers ...
(Date:7/3/2015)... ... 03, 2015 , ... The Erie County Bar Association Institute ... The Association welcomed speaker C. Daniel McGillicuddy Esq. of William Mattar Law Offices. ... investigating these types of cases. , Each year, New York State residents are ...
(Date:7/3/2015)... ... July 03, 2015 , ... " Selfie on a Stick ... the latest and coolest technology products available to consumers. Amanda Forstrom, a technology expert ... selfie sticks are great for documenting memories. , Almost every smartphone has an incredibly ...
(Date:7/2/2015)... ... , ... sweetFrog Enterprises, LLC. is pleased to announce the opening of its newest location in ... State. The premium frozen yogurt chain was listed as #22 on the Inc. 500 list ... Village at Bachman Lake, is located at:, 3701 W. Northwest Highway, STE 430, Dallas, TX ...
(Date:7/2/2015)... ... July 02, 2015 , ... Many Fourth of July celebrations will ... Amica Insurance is sharing some tips to promote the proper use of ... go to the emergency room daily with fireworks-related injuries in the month surrounding the ...
Breaking Medicine News(10 mins):Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 2Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 3Health News:Attorney from William Mattar Leads Discussion on Bicycle Accidents 2Health News:Learn How to Take Selfies like Kendall Jenner 2Health News:sweetFrog Opens 18th Location in the Lone Star State 2Health News:6 Fireworks Safety Tips from Amica Insurance 2
... Podcast from Perot Systems on the Role of Information Technology in Improving HealthcarePLANO, Texas, ... Dr. Harry Greenspun, executive vice president and chief, ... Guest: Dr. Nathaniel Hupert, Director of The Preparedness Modeling Unit, ... Centers for Disease Control and Prevention (CDC) and, ...
... their homes is the focus of Penn State,s portion ... that will also test the efficacy of a workplace ... "We,re seeing that stress in the workplace can create ... quality of life in families," says David Almeida, professor ...
... Ian Benjamin Named EBP Practice LeaderNEW YORK, April ... Pullen, LLP announced today a major expansion in ... practice in their New York office. The expansion ... partner with extensive experience in the EBP sector.(Logo: ...
... to Increasing Support for Men,s Health Issues in ... Health Network applauds Representatives Barron Hill (D-IN) and ... the "Men and Families Health Care Act of ... Men,s Health within the Department of Health and ...
... Innovation in the Anthelios Franchise for UVA and UVB ... La Roche-Posay, the company that brought the highly ... the availability of Anthelios 60 Sunscreen(1) beginning May 1st. ... new revolutionary sunscreen range offers high ...
... April 30, 2009 Biogen Idec (NASDAQ: BIIB) today ... (interferon beta-1a) Multiple Sclerosis (MS) Prevention Study In Ongoing ... (Controlled High Risk Subjects AVONEX MS Prevention Study). ... for use in patients who experienced their first clinical ...
Cached Medicine News:Health News:Looking Forward: The Use of Health IT in Crisis 2Health News:Looking Forward: The Use of Health IT in Crisis 3Health News:Looking Forward: The Use of Health IT in Crisis 4Health News:Penn State plays integral role in $35 million stress project 2Health News:RSM McGladrey and McGladrey & Pullen LLP Announce Major Expansion of Employee Benefits Plan Practice in New York 2Health News:RSM McGladrey and McGladrey & Pullen LLP Announce Major Expansion of Employee Benefits Plan Practice in New York 3Health News:U.S. Representatives Hill and Murphy Introduce the 'Men and Families Health Care Act of 2009' 2Health News:Photos: ANTHELIOS 60 Sunscreen(1) with CELL-OX SHIELD(TM) Available May 1 Nationwide 2Health News:Photos: ANTHELIOS 60 Sunscreen(1) with CELL-OX SHIELD(TM) Available May 1 Nationwide 3Health News:First ten-year follow-up shows that treatment with AVONEX leads to long-term benefits in early multiple sclerosis patients 2
(Date:7/3/2015)... , Mexique, July 3, 2015 ... continue cible les épidémies que sont l,hypertension, le ... par l,intermédiaire de plateformes éducatives gratuites et d,une ...      (Photo: http://photos.prnewswire.com/prnh/20150630/227033 ) , ... diabète en ligne , Prendre en charge ...
(Date:7/3/2015)... July 3, 2015  Obsidian HDS, the developer of ... service for the management of data on pharmaceutical and ... PharmaShine now includes the 2014 Open Payments General and ... on June 30. The data disclosed on Open Payments ... industry and providers totaling $6.49 billion and is the ...
(Date:7/2/2015)... SHENZHEN , Chine, 3 juillet 2015 ... séquençage à haut débit de l,ADN situé à ... la certification de  l,American College of Pathologists  (Collège ... BGI à Hong Kong ... nouvelle génération à recevoir la certification du CAP ...
Breaking Medicine Technology:Lutter contre trois maladies chroniques majeures en Amérique latine grâce à la formation médicale 2Lutter contre trois maladies chroniques majeures en Amérique latine grâce à la formation médicale 3New Open Payments (Sunshine Act) Data Now Searchable on PharmaShine 2BGI obtient la certification du Collège des pathologistes américains (CAP) 2
... Winner Medical Group Inc. (Nasdaq: WWIN ; "Winner ... medical disposables and non-woven fabric made from 100% natural PurCotton® ... present at the 2011 Brean Murray, Carret & Co. Beijing ... 28, 2011 at the JW Marriott Hotel located at 83 ...
... OncoSec Medical Incorporated (OTCBB: ONCS), a therapeutic oncology company ... cancers, announced today that Anthony E Maida, III, Ph.D., ... will chair its audit committee. (Logo: ... Dr. Maida has focused on clinical development of immunotherapies ...
Cached Medicine Technology:Winner Medical to Present at Brean Murray, Carret & Co. Beijing China Growth Conference 2Winner Medical to Present at Brean Murray, Carret & Co. Beijing China Growth Conference 3OncoSec Medical Announces the Appointment of Dr. Anthony E. Maida, III, to Its Board of Directors 2OncoSec Medical Announces the Appointment of Dr. Anthony E. Maida, III, to Its Board of Directors 3
Inquire...
... Sebia's Normal and Hypergamma Controls ... on either agarose gels or ... system. Our unique control manufacturing ... as the other serum components, ...
Eliminating the need for any manual pipetting, the HydraPLUS delivers precise micro-volumes of sample directly from primary tubes to four HYDRASYS sample applicators contained in a built-in humidity ...
Inquire...
Medicine Products: